1. The UCLA Institute for Precision Health (IPH) Dr. Allen and Charlotte Ginsburg (Ginsburg) Fellowship in Precision Genomic Medicine is intended to support exceptional postdoctoral trainees in the biological, clinical, and ethical/legal aspects of genetic and genomic medicine research.
  2. The optimal candidate will be a clinical fellow (PGY or Clinical Instructor Series) with protected research time during the award period. Assistant Professor candidates in their first year of their academic positions are also encouraged to apply.
  3. Candidates must have received an MD or MD-PhD from an accredited university, be enrolled in, or have completed a clinical residency or fellowship, and plan to pursue translational research with a mentor in some aspect of genomic medicine, considered broadly.
  4. Ginsburg post-doctoral fellows will receive a $75,000 annual award to support salary or necessary research supplies (including software).
  5. Funds may not be used to support the mentor’s research program or equipment.
  6. Applicants who are currently residents or fellows must present a letter from their residency/fellowship director indicating that they will be able to devote at least 80% time to research.
  7. An important goal of the fellowship program is to support individuals from diverse academic backgrounds including developmental biology, cell biology, neurobiology, molecular biology, biomedical informatics, tissue engineering, clinical medicine, law, and ethics. Accordingly, the fellowship encourages faculty mentors from the Schools of Dentistry, Engineering, Law, Medicine, Nursing, Public Health, and any academic unit in the UCLA College to sponsor applicants.
  8. Criteria for review of applications will include prior demonstrated interest in a career in academic medicine, the record of, or potential for, creative research accomplishments by the applicant, the relevance of the proposed project to genomic medicine and a commitment to diversity.
  9. Applications will be assessed by a diverse interdepartmental review committee.
  10. It is strongly encouraged that applications include evidence of departmental support beyond the initial fellowship year and a plan for the transition to faculty.
  11. An IPH Ginsburg fellow may be concurrently supported with another fellowship or similar award that provides a stipend.
  12. U.S. citizenship is not a requirement for participation in the training program.
  13. A laboratory may submit an application sponsoring only one candidate.
  14. Each fellow will have an assigned mentor who is an experienced clinical or basic scientist in areas related to genomic medicine including diseases or conditions that could potentially benefit from genetic/genomic research. The mentor’s letter of recommendation should include the mentor’s qualifications and experience as a mentor.
  15. The research plan should articulate the approaches and methods that you will use in your proposed research as well as a plan for how you will use the funds.
  16. The career development plan should clearly outline your clinical and research goals, how the additional training will help you achieve those goals, how your mentor will support your career development goals, and a timeframe in which your goals are to be accomplished. The goal is to help physician scientists transition to a successful academic career.
  17. The diversity statement should include past, present, and future (planned) contributions to equity, diversity, and inclusion.
  18. Award and subsequent award funds are non-transferable.
  19. Appointments will be made on an annual competitive basis as funds are available. Applications for a second year of funding will be considered but are generally discouraged. There will be one fellow selected for the 2024-2025 cycle.
  20. To be considered for the IPH Ginsburg Fellowship, applicants must complete and submit the completed application packet electronically to [email protected] by April 15, 2024.
  21. APPLICATIONS MUST USE 11 POINT ARIAL TYPE AND 0.5” MARGINS. Applications that use smaller font sizes (i.e., 10 point), are incomplete, improperly prepared, or exceed page limits will not be reviewed.